US equities
|
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Integra LifeSciences Holdings Corporation - Common Stock
(NQ:
IART
)
11.99
-0.11 (-0.91%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Integra LifeSciences Holdings Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Why Integra LifeSciences (IART) Shares Are Sliding Today
July 29, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu...
Via
StockStory
Topics
Earnings
Integra LifeSciences Q2 Earnings Call Highlights
↗
July 29, 2026
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and...
Via
MarketBeat
Topics
Earnings
World Trade
Integra LifeSciences (NASDAQ:IART) Surges Over 30% on Q2 Earnings Beat
↗
July 29, 2026
Via
Chartmill
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
July 29, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil...
Via
StockStory
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect
July 27, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here’s what to look for. Integra LifeSc...
Via
StockStory
Topics
Artificial Intelligence
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
July 24, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via
StockStory
Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm
July 23, 2026
From
Kaskela Law LLC
Via
Business Wire
3 Small-Cap Stocks with Warning Signs
July 17, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Why Integra LifeSciences (IART) Stock Is Up Today
July 09, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 4.3% in the afternoon session after BMO Capital initiated coverage ...
Via
StockStory
Topics
Artificial Intelligence
Earnings
3 Unpopular Stocks with Open Questions
June 29, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
1 Value Stock to Target This Week and 2 We Brush Off
June 26, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
Topics
Economy
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
June 22, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
Topics
Artificial Intelligence
Economy
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From
Biotech Insider
Via
GlobeNewswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From
World Street Intelligence
Via
GlobeNewswire
3 Profitable Stocks We’re Skeptical Of
June 15, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
June 09, 2026
Issued on behalf of Conexeu Sciences Inc.
From
Equity Insider
Via
GlobeNewswire
3 Reasons to Avoid IART and 1 Stock to Buy Instead
June 05, 2026
Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has climbed to $17.91, representing a he...
Via
StockStory
Topics
Bankruptcy
Stocks
Why Integra LifeSciences (IART) Stock Is Trading Up Today
May 28, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 6.1% in the afternoon session after Citigroup upgraded its rating o...
Via
StockStory
3 Inflated Stocks That Concern Us
May 26, 2026
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...
Via
StockStory
3 Stocks Under $50 with Open Questions
May 21, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via
StockStory
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
↗
May 17, 2026
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer...
Via
MarketBeat
Topics
Economy
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call
May 12, 2026
Integra LifeSciences delivered a first quarter that surpassed Wall Street expectations, as reflected by a significant positive market reaction. Management at...
Via
StockStory
Topics
Earnings
World Trade
Why Are Integra LifeSciences (IART) Shares Soaring Today
May 07, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 5.3% in the afternoon session after the company reported strong fir...
Via
StockStory
Integra (IART) Q1 2026 Earnings Call Transcript
↗
May 05, 2026
Integra (IART) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
Integra LifeSciences (NASDAQ:IART) Exceeds Q1 CY2026 Expectations
May 05, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.4% year on year to $391.9 mil...
Via
StockStory
What To Expect From Integra LifeSciences’s (IART) Q1 Earnings
May 03, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting earnings this Tuesday before the bell. Here’s what to expect. Integra LifeScience...
Via
StockStory
1 Value Stock to Research Further and 2 We Turn Down
April 28, 2026
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Via
StockStory
Topics
Supply Chain
3 Cash-Burning Stocks That Concern Us
April 21, 2026
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...
Via
StockStory
Integra LifeSciences (IART): Buy, Sell, or Hold Post Q4 Earnings?
April 17, 2026
What a brutal six months it’s been for Integra LifeSciences. The stock has dropped 28.1% and now trades at $10.84, rattling many shareholders. This might hav...
Via
StockStory
Q4 Rundown: Integra LifeSciences (NASDAQ:IART) Vs Other Surgical Equipment & Consumables - Specialty Stocks
April 14, 2026
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences...
Via
StockStory
Topics
Artificial Intelligence
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
